Suchergebnisse - "Ghalilah, Khalid"

PubPharm (7)

1

Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial) : An Open-Label, Multicenter, Randomized, Controlled Trial

enthalten in: Infectious diseases and therapy | 2021

von Bosaeed, M. | Mahmoud, E. | Alharbi, A. | +27

2

Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial

enthalten in: Infectious diseases and therapy | 2021

von Bosaeed, M. | Mahmoud, E. | Alharbi, A. | +27

3

Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial

enthalten in: Infectious diseases and therapy | 2021

von Bosaeed, M. | Mahmoud, E. | Alharbi, A. | +27

4

Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial

enthalten in: Infectious diseases and therapy | 2021

von Bosaeed, M. | Mahmoud, E. | Alharbi, A. | +27

5

Effects of Anticoagulants and Corticosteroids therapy in patients affected by severe COVID-19 Pneumonia

enthalten in: bioRxiv.org | 2021

von Ghalilah, K. | Sabir, A. | Alvi, I. | +6

6

Waterpipe smoking and the risk of myocardial infarction : A hospital-based case-control study

enthalten in: Tobacco induced diseases | 2019

von Al-Amri, A. | Ghalilah, K. | Al-Harbi, A. | +3

7

Middle East respiratory syndrome coronavirus in Al-Madinah City, Saudi Arabia: Demographic, clinical and survival data

in: Journal of Epidemiology and Global Health | 2019

von Nahid Sherbini | Ayman Iskandrani | Ayman Kharaba | +3

1
[1]